eujobs.coEU jobs in brussels
Post a JobHeadhunter

European Federation of Pharmaceutical Industries and Associations

Acronym: EFPIA

General Information

Identification Code: 38526121292-88
Website: [object Object]
Entity Form: Non-profit association
Registration Category: Trade and business associations
Registration Date: 3/4/2009
Last Update: 6/26/2024
EP Accredited Number: 7

Mission & Interests

Goals: EFPIA represents the biopharmaceutical industry operating in Europe. Through its direct membership of 37 national associations, 38 leading pharmaceutical companies, and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy. Our vision is for a healthier future for Europe. A future based on prevention, innovation, access to new treatments and better outcomes for patients. EFPIA’s activities extend to all matters of common interest to its members. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high-quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Budget
  • Business and industry
  • Climate action
  • Competition
  • Consumers
  • Customs
  • Digital economy and society
  • Employment and social affairs
  • Environment
  • External relations
  • Humanitarian aid and civil protection
  • Institutional affairs
  • International co-operation and development
  • Public health
  • Research and innovation
  • Single market
  • Trade
  • Trans-European Networks
Levels of Interest:
  • global
  • national
  • european

Activities

Main EU Legislative Proposals: Any health or pharmaceutical policy stemming from the European institutions, such as - but not exclusive - Industrial Policy, Pharmaceutical Strategy, pharmaceutical, orphan and paediatrics legislation, Horizon Europe Research Programme, HTA policy, IP policy, One Health Approach to tackle AMR, COVID-19 outbreak measures. EFPIA also follows ongoing trade negotiations and legislative files relevant to the innovative pharmaceutical industry (such as Green Deal, Water Framework Directive, Welfare of animals in scientific testing etc). Main EU legislative proposals or policies targeted (a non-exhaustive list) A Pharmaceutical Strategy for Europe – over 50 legislative and non-legislative proposals • Directive 2001/83/EC on the Community code relating to medicinal products for human use • Regulation (EC) No 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency • Regulation (EC) No 141/2000 of the European Parliament and of the Council on orphan medicinal products. • Regulation (EC) No 1901/2006 of the European Parliament and of the Council on medicinal products for paediatric use In addition, we also follow for example: • Clinical Trial Regulation • EMA Fees Regulation • Europe’s Beating Cancer Plan • European Health Data Space • HERA Regulation • SPCs Regulation revision
Communication Activities: EFPIA communications activities include: • Publishing new evidence (etc. reports, leaflets, infographics) on the policies mentioned above on efpia.eu • Drafting blog post to share opinions • Organising events including EFPIA members and external stakeholders • Disseminating our key messages through media and social media
EU Supported Forums and Platforms: Multistakeholder expert group to support the application of Regulation (EU) 2016/679#E03537#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3537 #MEMBER #C#IndustryTechnical Expert Group for the implementation of the Directive on the protection of animals used for scientific purposes#E02551#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2551 #MEMBER #C#IndustryConsultation Forum on Access and benefit sharing (ABS)#E03396#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3396 #MEMBER #C#IndustryExpert Group Global Gateway Business Advisory Group#E03898#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3898 #MEMBER #C#Industry06 - Borderline and Classification (B&C)#X03565/8#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100603 #OBSERVER #C#Industry08 - EUDAMED#X03565/13#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100886 #OBSERVER #C#Industry03 - Clinical Investigation and Evaluation (CIE)#X03565/5#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100600 #OBSERVER #C#IndustryAntimicrobial Resistance One Health Network#E03853#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3853 #MEMBER #C#Industry#SMEs04 - Post-Market Surveillance and Vigilance (PMSV)#X03565/6#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100601 #OBSERVER #C#Industry11 - In vitro Diagnostic Medical Devices (IVD)#X03565/12#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100608 #OBSERVER #C#IndustryCompetent Authorities' Expert Group on the protection of animals used for scientific purposes#E02539#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2539 #OBSERVER #C#OtherZero Pollution Stakeholder Platform#E03790#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3790 #MEMBER #C#IndustryeHealth Stakeholder Group#E02769#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2769 #MEMBER #C#Industry02 - Standards#X03565/4#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100599 #OBSERVER #C#IndustryGG BAG sub-group on Health Sector#E03898/3#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=104596 #MEMBER #C#Industry07 - New Technologies#X03565/9#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100604 #OBSERVER #C#IndustryMedical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #OBSERVER #C#Industry
Inter-institutional or Unofficial Groupings: Cancer

Head Office

Address: 8 Rue Mil Neuf Cents
Post Code: L-2157
City: Luxembourg
Country: LUXEMBOURG
Phone: [object Object]

EU Office

Address: Rue Montoyer 51 (Box 3)
Post Code: 1000
City: Brussels
Country: BELGIUM
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: According to our calculations, the declared above amount as per guidelines, is correct. The estimate of annual costs related to activities covered by the register covers personnel related expenses as well as the costs related to intermediary activities.

Membership Information

Members10 Percent: 4
Members25 Percent: 12
Members50 Percent: 14
Members75 Percent: 4
Members: 34
Members F T E: 13.399999618530273
Info Members: 34 staff members are involved, however as stated above, the calculation shows the full time equivalent for 13.4 people.

Structure

Structure Type: Structure
Is Member Of: EFPIA’s constituent entities include: • 38 corporate members (companies) • 37 member associations (national associations) • 16 SMEs • 31 Partners in Research http://www.efpia.eu/about-us/membership
Organisation Members: BIAC British Chamber of Commerce DIA EACD EAPM ECPA EPAA - European Partnership for Alternative Approaches to Animal EPC FAIB FEAM - Federation of European Academies of Medicine Friends of Europe Kangaroo Group Patients Access Partnership TOPRA THE EUROPEAN HOUSE – AMBROSETTI